RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sabzali Javadov to Myocardium

This is a "connection" page, showing publications Sabzali Javadov has written about Myocardium.
Connection Strength

2.103
  1. Escobales N, Nu?ez RE, Javadov S. Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019 06 01; 316(6):H1426-H1438.
    View in: PubMed
    Score: 0.575
  2. Chapa-Dubocq X, Makarov V, Javadov S. Simple kinetic model of mitochondrial swelling in cardiac cells. J Cell Physiol. 2018 07; 233(7):5310-5321.
    View in: PubMed
    Score: 0.528
  3. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol. 2003 Jun 01; 549(Pt 2):513-24.
    View in: PubMed
    Score: 0.190
  4. Kuznetsov AV, Javadov S, Grimm M, Margreiter R, Ausserlechner MJ, Hagenbuchner J. Crosstalk between Mitochondria and Cytoskeleton in Cardiac Cells. Cells. 2020 01 16; 9(1).
    View in: PubMed
    Score: 0.152
  5. Javadov S, Jang S, Parodi-Rull?n R, Khuchua Z, Kuznetsov AV. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? Cell Mol Life Sci. 2017 08; 74(15):2795-2813.
    View in: PubMed
    Score: 0.125
  6. Huang Y, Powers C, Madala SK, Greis KD, Haffey WD, Towbin JA, Purevjav E, Javadov S, Strauss AW, Khuchua Z. Cardiac metabolic pathways affected in the mouse model of barth syndrome. PLoS One. 2015; 10(6):e0128561.
    View in: PubMed
    Score: 0.110
  7. Lebedeva LG, Aleksandrova SS, Kiselar' ZhG, Kirsanova ID, Dzhavadov SA, Basnak'ian AG, Votrin II. [Study of the spectrum of rabbit myocardium nuclear DNAases using models of ischemia and diabetes mellitus]. Vopr Med Khim. 1995 Jul-Aug; 41(4):2-4.
    View in: PubMed
    Score: 0.055
  8. Lebedeva LG, Aleksandrova SS, Kirsanova ID, Basnak'ian AG, Dzhavadov SA, Votrin II. [Nuclear endo-DNAse from rabbit myocardium in ischemia and diabetes mellitus]. Vopr Med Khim. 1995 May-Jun; 41(3):9-11.
    View in: PubMed
    Score: 0.055
  9. Javadov S, Huang C, Kirshenbaum L, Karmazyn M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol. 2005 Jan; 38(1):135-43.
    View in: PubMed
    Score: 0.053
  10. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res. 2004 Feb 15; 61(3):372-85.
    View in: PubMed
    Score: 0.050
  11. Kuznetsov AV, Veksler VI, Sharov VG, Dzhavadov SA, Saks VA. [Quantitative relationship between ischemic heart disease and parameters of energy metabolism]. Vestn Ross Akad Med Nauk. 1992; (3):21-6.
    View in: PubMed
    Score: 0.043
  12. Seppet EK, Kallikorm AP, Dzhavadov SA, Preobrazhenskii AN, Lakomkin VA. [Energy-related disorders of myocardial contractility in calcium overload of the cardiomyocytes]. Kardiologiia. 1987 Jul; 27(7):72-6.
    View in: PubMed
    Score: 0.032
  13. Preobrazhenskii AN, Dzhavadov SA, Saks VA. [Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium]. Biokhimiia. 1986 Apr; 51(4):675-83.
    View in: PubMed
    Score: 0.029
  14. Dzhavadov SA, Preobrazhenskii AN, Saks VA. [Effect of phosphocreatine on the lysophosphoglyceride levels in total ischemia of the rat myocardium]. Biokhimiia. 1986 Apr; 51(4):668-74.
    View in: PubMed
    Score: 0.029
  15. Dzhavadov SA, Preobrazhenskii AN, Lakomkin VL, Kupriianov VV, Saks VA. [Various aspects of protective effect of exogenous phosphocreatine on the ischemic myocardium]. Vestn Akad Med Nauk SSSR. 1986; (12):58-67.
    View in: PubMed
    Score: 0.029
  16. Saks VA, Kapelko VI, Kupriyanov VV, Kuznetsov AV, Lakomkin VL, Veksler VI, Sharov VG, Javadov SA, Seppet EK, Kairane C. Quantitative evaluation of relationship between cardiac energy metabolism and post-ischemic recovery of contractile function. J Mol Cell Cardiol. 1989 Feb; 21 Suppl 1:67-78.
    View in: PubMed
    Score: 0.018
  17. Sharov VG, Saks VA, Kupriyanov VV, Lakomkin VL, Kapelko VI, Javadov SA. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg. 1987 Nov; 94(5):749-61.
    View in: PubMed
    Score: 0.016
  18. Anyukhovsky EP, Javadov SA, Preobrazhensky AN, Beloshapko GG, Rosenshtraukh LV, Saks VA. Effect of phosphocreatine and related compounds on the phospholipid metabolism of ischemic heart. Biochem Med Metab Biol. 1986 Jun; 35(3):327-34.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support